Volume 34, No 7, Jul 2024

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 34 Issue 7, July 2024: 467-468

RESEARCH HIGHLIGHTS

Immunotherapy for atherosclerosis by targeting pro-inflammatory T cells

Amir Khan , Klaus Ley^*

Immunology Center of Georgia, Augusta University, Augusta, GA, USA
Correspondence: Klaus Ley(kley@augusta.edu)

Recent advancements in atherosclerosis management have shifted focus beyond lipid-lowering strategies towards addressing residual inflammatory risks associated with major adverse cardiovascular events. In a recent Cell Research paper, Fan et al. reported that anti-PD-1 monoclonal antibody therapy reduces atherosclerosis plaque size and modulates inflammation by serving as a surrogate PD-1 ligand through interaction with myeloid-expressed Fc gamma receptors.

https://doi.org/10.1038/s41422-024-00955-y

FULL TEXT | PDF

Browse 144